Cash or convenience? new study probes why kidney patients choose home dialysis

NCT ID NCT07535320

Recruiting now Knowledge-focused Sponsor: University Hospital, Caen Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study asks 500 adults with advanced kidney disease to complete a questionnaire that presents different dialysis options. Patients choose between home dialysis (with a financial allowance) and in-center dialysis (without the allowance) 13 times, each with varying features like schedule flexibility and nurse support. The goal is to understand how much financial compensation and other factors influence their treatment choice. The results could help shape policies to make home dialysis more accessible.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help design better financial support programs that encourage home dialysis, potentially improving quality of life for kidney patients.
What could go wrong: This is an observational survey, not a treatment trial. It measures preferences, not outcomes, so it cannot prove that financial incentives actually lead to better health or wider home dialysis adoption.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE CHRONIC RENAL FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END STAGE CHRONIC RENAL FAILURE

Contacts and locations

Locations

CHU
RECRUITING

Caen, 14000, France
CHU de Caen
RECRUITING

Caen, 14000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.